http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02064124-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60b45602e00f5a41eb8e46a284b41d9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c14c21a87652606030ed1a99300d2e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6a03c589be782d12d8e5ad2e662772
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 2002-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03e845d72cc9a384bbf8fdc697a7c16a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ab3ef622218412f7512522dccadd814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4071427e1077f49cfca389c3545ffa3a
publicationDate 2002-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02064124-A2
titleOfInvention Medicament formulation containing a muscarinic agonist
abstract The invention relates to a novel medicament formulation containing the muscarinic agonist talsaclidine and to a method for the production thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9402907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2140867-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2140867-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2140867-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9918975-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010033045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9149532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707296-B2
priorityDate 2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9830243-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9846601-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0370415-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9846225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19851126-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127754342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3024046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136075176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226554022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928

Total number of triples: 52.